Showing results (251-260 of 259) with videos related to
Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 259 results.
Physical Review Letters|October 26, 2002
Surface-roughness wakefield measurements at brookhaven accelerator test facilityF Zhou, J H Wu, M Babzien, et al.Clinical Transplants|January 1, 1991
Liver transplantation in the United States: 1988 to 1990S H Belle, K C Beringer, J B Murphy, et al.Urology|April 17, 2010
Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinomaT V Johnson, A Abbasi, A Owen-Smith, et al.Current Biology : CB|April 21, 1999
Inverse relationship between systemic resistance of plants to microorganisms and to insect herbivoryG W Felton, K L Korth, J L Bi, et al.Physical Review Letters|August 26, 2003
First ultraviolet high-gain harmonic-generation free-electron laserL H Yu, L DiMauro, A Doyuran, et al.Oncogene|June 1, 2011
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasisS Zhang, X Wang, A O Osunkoya, et al.Cancer Research|April 15, 1997
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transferJ W Simons, E M Jaffee, C E Weber, et al.Cancer Research|October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transferJ W Simons, B Mikhak, J F Chang, et al.Cancer Chemotherapy and Pharmacology|August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignanciesW G Nelson, J W Simons, B Mikhak, et al.Pageof 26